Poster Presentations
112 - Small CRISPR RNAs guide antiviral defense in prokaryotes
Magnus Lundgren, Postdoctoral fellow, Wageningen University
104 - Conservation of the Mitf gene and the effect of microRNA on Mitf
Benedikta Haflidadottir, Graduate Student, University of Iceland
105 - Inhibition of Niemann-pick C1 like 1(NPC1L1) gene expression by RNAi
Divya Khanna, SRF,CSIR, Punjabi University,Patiala
106 - microRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the receptor Tyrosine-Kinase Ligand Ephrin-A3
Pasquale Fasanaro, Researcher, Istituto Dermopatico dell'Immacolata, IRCCS
110 - Studying the Effect of Silencing the Beta-Catenin and Aldose Reductase Genes using ?siRNAs in the Colon Cancer Cell Line HT-29?
Mehdi Forouzandeh, Academic Staff, Tarbiat Modares University
111 - Potential use of RNAi on Human Skin
Christine Collin-Djangone, Project Manager, LOREAL Research
113 - Normalization of microRNA Expression Data of Human Germ Cell Tumors and Controls
Astrid Ferlinz, Senior Application Specialist, Applied Biosystems
114 - Silencing of 14-3-3zeta Inhibits Cell Proliferation and Enhances Chemosensitivy of Cis-diammined dichloridoplatium in Hepatocellular Carcinoma Cell
Jung Eun Choi, Ph.D. Candidate, The Catholic University of Korea
115 - RNA interference in Manduca Sexta Induced by Double-Stranded RNA Feeding
Isabel Gomez, Assistant Researcher, Instituto de Biotecnologia-UNAM
116 - MicroRNAs Affect Gene Expression in a Range of Cells During Retinal Development
Jasenka Guduric-Fuchs, Postdoctoral research fellow, Queen's University Belfast
117 - Oligonucleotides with locked nucleic acid and targeting of biologically important RNAs
Peter Guterstam, PhDStudent, Stockholm University
118 - Evaluation of siRNA Uptake in vivo in Target Tissues Using PCR-Based Quantification or in-situ Hybridization
Hagar Kalinski, Senior Director Research, Quark Pharmaceuticals Inc.
119 - RNAi in Zebrafish
Amanda Kelly, PhD Student, University of Manchester
120 - Altered expression of miR-18a in differentiating, cultured, human oral keratinocytes
Cuong Khuu, Ph.D Student, University of Oslo
121 - Construction of Complex RNAi Libraries for Positive and Negative Phenotypic Selection of Target Genes
Igor Mett, Senior Scientist, Quark Pharmaceuticaks, Inc
122 - The Role of Mitosin in Bovine Preimplantation Development
Tereza Moravcova, PhD. Student, Institute of Animal Physiology and Genetics
123 - Quality control of miRNA in biological extractions
Ruediger Salowsky, Product Manager, Agilent Technologies
124 - Heterochromatin structure is induced by siRNA targeting HIV-1 promoter region
Kazuo Suzuki, Senior Hospital Scientist, St Vincent's Hospital
125 - RNA interference of myosin Va exon F isoforms in primary human melanocytes: an alternative to treat hyperpigmentation
Mireille Van Gele, Postdoctoral research fellow, Ghent University Hospital
126 - Cytosolic nanogel depots for time-controlled siRNA release Koen Raemdonck, PhD student, Ghent University
127 - Screening a library of siPLexes with various lipid compositions in vitro for future applicability in vivo
Kevin Buyens, PhD Student, Ghent University
128 - Efficient downregulation of the lung liquid clearing gammaENaC subunit by RNAi
Nihal Yueksekdag, PhD student, LMU Munich
129 - siRNA Overhangs Modifications to Enhance Gene Silencing
Marie-Elise Bonnet, Research Associate, Polyplus Transfection
130 - Pre-clinical evaluation of anti-Tissue Factor siRNA for inhibition of metastasis
Mohammed Amarzguioui, Research Director, siRNAsense AS
131 - Stealth™ RNAi for in vivo Applications
Xavier de Mollerat du Jeu, Sr Scientist, Invitrogen
132 - On the way to resolve miRNA-target interaction
Caroline Thurner, PostDoc, Medical University of Vienna
133 - Ageing regulated miRNAs in skeletal muscle and in mice
Junlong Zhang, Assistant Prof, Clinical Sciences Research Institute
134 - In Vitro potency of chemically modified siRNAs against TNF-a
Sandra Milena Ocampo, PhD student, University of Barcelona
135 - Genome-scale RNAi analysis of ß1 integrin regulation in prostate cancer cells using a novel cell spot microarray technology
Juha Rantala, PhD student, VTT Technical Research Centre of Finland
136 - A COMPARISON OF SIRNA ACTIVITY PREDICTORS USING ADVANCED REGRESSION TECHNIQUES
Simone Sciabola, Senior Scientist, Pfizer
137 - Novel nanoparticles in delivery of siRNA
Malin Mejare, Product Specialist, Genovis
138 - Targeting Inflammatory Cytokines Using Adenoviruses- gene delivery of biological therapies in ovarian cancer
Michael Salako, Postdoctoral Fellow, Institute of Cancer and the Cancer Research UK Clinical Centre
139 - Altered microRNA expression in mouse models of retinitis pigmentosa
Arpad Palfi, Research Fellow, Trinity College Dublin
140 - Validating microRNA biomarkers and their mRNA Targets in Primary Breast Tumors
Christopher Cunning, Invitrogen Corporation
141 - Coupling of anion-exchange LC, Enzyme digestion, and mass spectrometry to assay 2´-5´ linkage isomers in RNA
Thayer Dionex Corporation
142 - Quantification of siRNAs by Real Time PCR
Pérez CICbiogune
143 - Functional studies in primary neurons using a novel, high efficiency method of siRNA delivery
Tamara Seredenina, Postdoc, SienaBioetch S.p.A.